Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.
2.

Development of a Novel Enzyme-Targeting Radiosensitizer (New KORTUC) Using a Gelatin-Based Hydrogel Instead of a Sodium Hyaluronate.

Morita-Tokuhiro S, Ogawa Y, Yokota N, Tsuzuki A, Oda H, Ishida N, Aoyama N, Nishioka A.

Cancers (Basel). 2016 Jan 7;8(1). pii: E10. doi: 10.3390/cancers8010010.

3.

Serial Assessment of Therapeutic Response to a New Radiosensitization Treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), in Patients with Stage I/II Breast Cancer Using Breast Contrast-Enhanced Magnetic Resonance Imaging.

Yaogawa S, Ogawa Y, Morita-Tokuhiro S, Tsuzuki A, Akima R, Itoh K, Morio K, Yasunami H, Onogawa M, Kariya S, Nogami M, Nishioka A, Miyamura M.

Cancers (Basel). 2015 Dec 22;8(1). pii: E1. doi: 10.3390/cancers8010001.

4.

Dysphagia causes exacerbations in individuals with chronic obstructive pulmonary disease.

Tsuzuki A, Kagaya H, Takahashi H, Watanabe T, Shioya T, Sakakibara H, Kanada Y, Saitoh E.

J Am Geriatr Soc. 2012 Aug;60(8):1580-2. doi: 10.1111/j.1532-5415.2012.04067.x. No abstract available.

PMID:
22889024
5.

Evaluation of Changes in Tumor Shadows and Microcalcifications on Mammography Following KORTUC II, a New Radiosensitization Treatment without any Surgical Procedure for Elderly Patients with Stage I and II Breast Cancer.

Tsuzuki A, Ogawa Y, Kubota K, Tokuhiro S, Akima R, Yaogawa S, Itoh K, Yamada Y, Sasaki T, Onogawa M, Yamanishi T, Kariya S, Nogami M, Nishioka A, Miyamura M.

Cancers (Basel). 2011 Sep 9;3(3):3496-505. doi: 10.3390/cancers3033496.

Supplemental Content

Loading ...
Support Center